Skip to main content

Taysha Pediatric Gene Therapy Trial Is Open for Enrollment in US

December 27, 2023
Taysha Gene Therapies reports on safety and efficacy results for the first patient to receive gene therapy for Rett Syndrome

On December 27, 2023 Taysha Gene Therapies announced that their REVEAL pediatric gene therapy clinical trial is open for enrollent in the US. The first phase of the study is for children ages 5 to 8 while the second phase will expand the ages to include 3 to 8 years old. In total up to 27 patients will be enrolled. Two doses of the gene therapy will be tested. Rush University Medical Center in Chicago is currently the only clinic enrolling patients but there will be a total of 8 clinics eventually recruiting.

Read the community letter from Taysha for additional details.